Kim Youl-Ri, Kim Jeong Hyun, Kim Se Joo, Lee Dongeun, Min Sung Kil
Department of Neuropsychiatry, Seoul-Paik Hospital, Inje University, Seoul, South Korea.
Eur Neuropsychopharmacol. 2008 Nov;18(11):820-5. doi: 10.1016/j.euroneuro.2008.07.009. Epub 2008 Sep 11.
We examined the association between the Catechol-O-methyltransferase (COMT) Val158Met polymorphism and aggressive schizophrenia. The sample included 61 aggressive schizophrenic patients as well as 104 non-aggressive patients from psychiatric hospitals and 415 healthy volunteers in South Korea. In the case-control comparisons, there was no significant association between the aggressive schizophrenic patients and the COMT Val158Met polymorphism. Looking only at the subgroup of aggressive schizophrenic patients, however, we found a dose-dependent relationship between the Met allele and verbal aggression. In this subgroup, the Met carriers showed a higher verbal aggression score than those with the Val/Val homozygote. These findings support the hypothesized moderating role of the COMT gene in the aggressive behaviour in some schizophrenic patients, though they do not support the existence of a direct association between the COMT Val158Met polymorphism and aggressive schizophrenia case status in the Korean population.
我们研究了儿茶酚-O-甲基转移酶(COMT)基因Val158Met多态性与攻击性精神分裂症之间的关联。样本包括来自韩国精神病院的61例攻击性精神分裂症患者、104例非攻击性患者以及415名健康志愿者。在病例对照比较中,攻击性精神分裂症患者与COMT Val158Met多态性之间无显著关联。然而,仅观察攻击性精神分裂症患者亚组时,我们发现Met等位基因与言语攻击性之间存在剂量依赖关系。在该亚组中,Met携带者的言语攻击性得分高于Val/Val纯合子患者。这些发现支持了COMT基因在某些精神分裂症患者攻击行为中起调节作用的假设,尽管它们并不支持在韩国人群中COMT Val158Met多态性与攻击性精神分裂症病例状态之间存在直接关联。